Pathology Research International

240 papers and 4.4k indexed citations i.

About

The 240 papers published in Pathology Research International in the last decades have received a total of 4.4k indexed citations. Papers published in Pathology Research International usually cover Oncology (72 papers), Surgery (61 papers) and Molecular Biology (51 papers) specifically the topics of Breast Cancer Treatment Studies (19 papers), Breast Lesions and Carcinomas (18 papers) and Cancer and Skin Lesions (14 papers). The most active scholars publishing in Pathology Research International are Jitendra Singh Nigam, Liron Pantanowitz, Enrique Rengifo, Eduardo Cambruzzi and Tibor Tot.

In The Last Decade

Fields of papers published in Pathology Research International

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Pathology Research International. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Pathology Research International

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Pathology Research International. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Pathology Research International with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025